Baron ... I submitted 3 questions earlier in the week but they were not addressed. The session was entirely about technical progress and business development was not on the agenda for the quarterly review. My questions (which were not addressed) were:
Q1 ... At the last quarterly you described the feedback from some pharma companies as "super,super encouraging". Have the follow up discussions been just as encouraging and what feedback are we getting?
Q2 ... Is a financial deal (licence, programme partner, company JV etc) likely in the next 6 months, noting that raising more money at 5.5c to run 2 then 3 clinical programmes will be terribly diluting?
Q3 ... On the ASX it seems that there is active price suppression occurring. Are there any tactics to counteract this behaviour? Each good news announcement has about 1 day of sunshine then the price drops to below where it was prior to the announcement. Price drops also occur when turnover volume increases - how does that happen?
I'll have to wait till the next quarterly for answers.
Ann: Q3 Investor Call 27 September 2023, page-15
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.0¢ | $392.3K | 3.706M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 1506182 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 1714856 | 9 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.000 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 10.8¢ | 11.0¢ | 10.5¢ | 1029511 | ||
| Last updated 15.58pm 22/05/2024 ? | |||||
| PYC (ASX) Chart |